Reduced antibody activity against SARS-CoV-2 B.1.617.2 delta virus in serum of mRNA-vaccinated individuals receiving tumor necrosis factor-α inhibitors
Rita E. Chen, Matthew J. Gorman, Daniel Y. Zhu, Juan Manuel Carreño, Dansu Yuan, Laura A. VanBlargan, Samantha Burdess, Douglas A. Lauffenburger, Wooseob Kim, Jackson S. Turner, Lindsay Droit, Scott A. Handley, Salim Chahin, Parakkal Deepak, Jane A. O’Halloran, Michael Paley, Rachel M. Presti, Gregory F. Wu, Florian Krammer, Galit Alter, Ali H. Ellebedy, Alfred H.J. Kim, Michael Diamond
Topics & Concepts
MedicineImmunologyAntibodyNeutralizing antibodyImmunosuppressionAntibody titerVirusImmunizationImmune systemVirologyContext (archaeology)VaccinationTumor necrosis factor alphaViral sheddingTiterNeutralizationBiologyPaleontologySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studiesvaccines and immunoinformatics approaches